MRE0094

DRUG2 trials

Sponsors

Pfizer

Conditions

Diabetes ComplicationsFoot Ulcer, Diabetic

Phase 2

Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers

CompletedNCT00312364

PfizerDiabetes Complications, Foot Ulcer, Diabetic

Start: 2005-12-31End: 2007-12-31Updated: 2012-06-01

Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers

TerminatedNCT00318214

PfizerDiabetes Complications, Foot Ulcer, Diabetic

Start: 2006-06-30End: 2008-02-29Updated: 2012-06-01